Briefs

FDA warns 5 CBD makers in U.S.

Share this:

Five American CBD makers have been warned by the U.S. Food and Drug Administration for making illegal medical claims in the agency’s most recent crackdown. FDA informed the companies that their claims violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA sent the warnings to Bee Delightful of Austin, Texas; G&L Wellness of Wisconsin Rapids, Wisconsin; New Leaf Pharmaceuticals of Newton, Connecticut; NextL3vel Services Group of Las Vegas, Nevada; and Wellness Biosciences Rx of Houston, Texas. FDA continues to work on clear rules for CBD but occasionally reprimands companies who violate the FD&C Act.

Recent Posts

Native American alliance hopes to spark cannabis on tribal lands

The Native American Cannabis Alliance (NACA) said it signed memoranda of understanding with indigenous farmers…

September 21, 2021

UK project aimed at accelerating hemp as as biorefinery crop

A project aimed at accelerating the use of hemp as a biorefinery crop is among…

September 21, 2021

Majority of German parties agree changes needed on hemp

Four of six German political parties generally agree that hemp should not be under the…

September 20, 2021

Czech president expected to sign law raising THC limit to 1.0%

Czech President Miloš Zeman is expected to sign a bill that would set the limit…

September 17, 2021

Plastics startup off to fast start after raising $1 million via crowdfunding

Startup Canadian Industrial Hemp Corporation (CIHC) said it has raised more than $1 million of…

September 16, 2021

Hemp takes a foothold in grain, fiber in South Dakota’s first year

South Dakota farmers are harvesting hemp on 1,600 acres in 2021, and state officials say…

September 15, 2021